Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at Fresno, California
Dates
study started
completion around
Principal Investigator
by Michael Darracq, MD, MPH
Headshot of Michael Darracq
Michael Darracq

Description

Summary

The goal of this study is to examine patients undergoing incision and drainage of cutaneous abscesses to determine if routine packing of the abscess cavity affects the need for further interventions such as repeat incision and drainage, antibiotic administration or hospital admission.

Official Title

Is Routine Packing of Cutaneous Abscesses Necessary?

Details

Study protocol:

  1. Identification of a patient with a cutaneous abscess requiring incision and drainage
  2. Written consent obtained from the patient
  3. Study materials will be obtained
    • Enrolling physician fills out pre-procedure information (see data sheet)
    • Enrollment data sheet has instructions indicating whether patient is to receive packing or not

      - Use of random number generator to randomize all packets

    • Provider does abscess incision and drainage with or without packing according to the instructions
    • Enrolling physician fills out post-procedure information (see data sheet)
    • Patient returns within 48 hours for wound check with removal of packing if performed
    • Research coordinator or study physician calls the patient within 14 and 30 days after the procedure for follow-up

      - Information from a return visit and/or the telephone follow-up

Keywords

Cutaneous Abscess, Abscess, Skin Diseases, Packing, No packing

Eligibility

You can join if…

Open to people ages 18 years and up

  1. All patients 18 years of age and above
  2. Patients that require a cutaneous abscess incision and drainage
  3. English-speaking subjects only

You CAN'T join if...

  1. Unable to return for 48-hour follow-up.
  2. Patients being admitted to the hospital or going to the operating room for incision and drainage
  3. Pregnant patients
  4. Patients less than 18 years of age
  5. Prisoners or persons in police custody
  6. Patients with infected bursa
  7. Non-English speaking subjects

Location

  • Community Regional Medical Center accepting new patients
    Fresno California 93701 United States

Lead Scientist at UCSF

  • Michael Darracq, MD, MPH
    Michael Darracq, MD, MPH, FACEP, FACMT, FAWM Professor of Clinical Emergency Medicine, UCSF Co-Director of Medical Toxicology, UCSF Fresno Michael A. Darracq, MD, MPH is board certified in Emergency Medicine, Medical Toxicology, and Addiction Medicine. Dr. Darracq received a BS magna cum laude from the University of California, San Diego and a MD from the University of California, Davis.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT02822768
Study Type
Interventional
Participants
Expecting 196 study participants
Last Updated